Each dose level serves a purpose, building toward the therapeutic levels that produce the impressive 22.5% average weight loss seen in clinical trials
Common amounts include 1mg, 5mg, 10mg, or 15mg
Superior Effects on Fatty Liver (NAFLD/NASH) Fatty liver disease is a major consequence of obesity and insulin resistance, affecting up to 25% of the global population
However, it may also cause nausea or vomiting in some people, especially during the first few weeks of treatment
The new work is the first to suggest that this type of drug could have such a protective effect in people, says behavioral neuroscientist Patricia Sue Grigson of Penn State College of Medicine in Hershey
Gaining insight into its mechanisms and dosing is key to seeing how it compares to other options